PRRT2 and diabetic kidney disease: The abnormal glucose metabolism in patients with DKD is characterized by the increased production of advanced glycation end products (AGEs), activation of the protein kinase C (PKC) pathway, and enhanced polyol pathways, which play a significant role in promoting the development of DKD (59).